Dr. Jha is a research fellow in the Department of Diabetes, where he leads projects focused on identifying novel therapeutic targets and biomarkers for diabetes and kidney disease. He completed his PhD at Monash University in 2014, and the outcomes of his thesis provided the rationale for clinical trials of NOX inhibitors in diabetic kidney disease. In 2015, he began his postdoctoral research at the Baker Heart and Diabetes Institute. In 2016, he received the prestigious Juvenile Diabetes Research Foundation (JDRF) International Postdoctoral Fellowship to continue his work on diabetes and kidney disease. In 2017, he was awarded the highly prestigious NHMRC Early Career Research Fellowship, at which point he transitioned to the newly established Monash Diabetes Department. Additionally, he spent three months as a visiting scholar at the German Diabetes Centre in Düsseldorf in 2022.

Dr. Jha is a member of the Australian Diabetes Society (ADS), the Australian and New Zealand Society of Nephrology (ANZSN), the American Society of Nephrology (ASN), and the European Association for the Study of Diabetes (EASD). The quality of his research outputs is reflected in his highly cited publications in leading journals in diabetes and nephrology, as well as in securing fellowships and grants, including recent grants from Diabetes Australia (2020, 2022, 2023, 2024). These achievements underscore the significance of his work in the field.

• Oxidative stress – inflammation – fibrosis axis in diabetes and related complications
• Human 3D kidney organoids
• Translation of novel therapeutic targets
• NOX pathways
• Predictive tools and biomarkers of diabetes and kidney disease